Chengcheng Zhang

13PUBLICATIONS
78CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 09, 2026
Leukocyte immunoglobulin-like receptor A3 inhibits the activity of immunosuppressive myeloid cells.

|Apr 03, 2026
Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer.

Xiaoye Liu, Ryan Huang, Zhiqiang Ku

|Mar 13, 2026
IL-7/IL-15/IL-21 cytokine-fusion scaffold generates highly functional CAR T cells enriched in long-lived T memory stem cells.

Erin B Cole, Sara Lamcaj, Agnes V Sydenstricker

|Nov 13, 2025
Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptors.

Chengcheng Zhang, Yubo He, Xiaoye Liu

|Jul 24, 2025
Secretogranin 2 binds LILRB4 resulting in immunosuppression.

Xing Yang, Ryan Huang, Meng Fang

|Mar 27, 2025
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development.

Yubo He, Chengcheng Zhang, Lingxiao Tan

Pageof 3

Frequent Collaborators

6 joint publications

Zhiqiang An

5 joint publications

Ningyan Zhang

4 joint publications

Cheryl M Lewis

4 joint publications

Chengcheng Zhang